Inhibition Peroxiredoxin‐2 by Capsaicin Ameliorates Rheumatoid Arthritis via ROS‐Mediated Apoptosis in Fibroblast‐Like Synoviocytes
ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing prop...
Saved in:
Published in | MedComm (2020) Vol. 6; no. 6; pp. e70209 - n/a |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
China
John Wiley & Sons, Inc
01.06.2025
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT
Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA.
Capsaicin attenuating arthritis by inhibiting AKT phosphorylation and activating the NRF2–HO‐1 axis via targeting PRDX2 |
---|---|
AbstractList | ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation-inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity-based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti-inflammatory and antiproliferative effects on fibroblast-like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA.Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation-inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity-based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti-inflammatory and antiproliferative effects on fibroblast-like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L ., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. Capsaicin attenuating arthritis by inhibiting AKT phosphorylation and activating the NRF2–HO‐1 axis via targeting PRDX2 ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from Capsicum annuum L., is known for its burning sensation‐inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity‐based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti‐inflammatory and antiproliferative effects on fibroblast‐like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. Capsaicin attenuating arthritis by inhibiting AKT phosphorylation and activating the NRF2–HO‐1 axis via targeting PRDX2 Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues, leading to joint inflammation and damage. Capsaicin (CAP), from ., is known for its burning sensation-inducing property and has shown various pharmacological effects, yet its specific mechanisms and targets in RA treatment remain largely unclear. This study aimed to investigate the role of CAP in RA by synthesizing CAP probes and using activity-based protein profiling. We found that CAP reduced joint swelling in arthritic mice and exerted anti-inflammatory and antiproliferative effects on fibroblast-like synoviocytes. We identified that CAP binds to PRDX2, inhibiting its antioxidant function and inducing oxidative stress and apoptosis, contributing to the antiarthritic effects. These results suggest that PRDX2 is a potential target for CAP in RA treatment, providing new insights into the molecular mechanisms and potential therapeutic strategies for RA. |
Author | He, Hengkai Chen, Junhui Huang, Jingnan An, Yehai He, Ruiyi Zhang, Qian Hao, Mingjing Luo, Piao Du, Qingfeng Wang, Jigang |
AuthorAffiliation | 5 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing China 4 Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases Guangzhou China 3 Department of Pulmonary and Critical Care Medicine Shenzhen Institute of Respiratory Diseases and Shenzhen Clinical Research Centre for Geriatrics Shenzhen People's Hospital First Affiliated Hospital of Southern University of Science and Technology Second Clinical Medical College of Jinan University Shenzhen Guangdong China 1 Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics School of Traditional Chinese Medicine and School of pharmaceutical Sciences Southern Medical University Guangzhou China 2 State Key Laboratory of Southwestern Chinese Medicine Resource School of Pharmacy Chengdu University of Traditional Chinese Medicine Chengdu Ch |
AuthorAffiliation_xml | – name: 5 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing China – name: 3 Department of Pulmonary and Critical Care Medicine Shenzhen Institute of Respiratory Diseases and Shenzhen Clinical Research Centre for Geriatrics Shenzhen People's Hospital First Affiliated Hospital of Southern University of Science and Technology Second Clinical Medical College of Jinan University Shenzhen Guangdong China – name: 1 Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics School of Traditional Chinese Medicine and School of pharmaceutical Sciences Southern Medical University Guangzhou China – name: 4 Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases Guangzhou China – name: 2 State Key Laboratory of Southwestern Chinese Medicine Resource School of Pharmacy Chengdu University of Traditional Chinese Medicine Chengdu China |
Author_xml | – sequence: 1 givenname: Hengkai surname: He fullname: He, Hengkai organization: Chengdu University of Traditional Chinese Medicine – sequence: 2 givenname: Mingjing surname: Hao fullname: Hao, Mingjing organization: Second Clinical Medical College of Jinan University – sequence: 3 givenname: Piao surname: Luo fullname: Luo, Piao organization: Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases – sequence: 4 givenname: Junhui surname: Chen fullname: Chen, Junhui organization: Second Clinical Medical College of Jinan University – sequence: 5 givenname: Yehai surname: An fullname: An, Yehai organization: Southern Medical University – sequence: 6 givenname: Jingnan surname: Huang fullname: Huang, Jingnan organization: Second Clinical Medical College of Jinan University – sequence: 7 givenname: Ruiyi surname: He fullname: He, Ruiyi organization: Southern Medical University – sequence: 8 givenname: Qingfeng surname: Du fullname: Du, Qingfeng email: dqf1689@smu.edu.cn organization: Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases – sequence: 9 givenname: Qian surname: Zhang fullname: Zhang, Qian email: zhangqian408@yeah.net organization: Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases – sequence: 10 givenname: Jigang orcidid: 0000-0002-0575-0105 surname: Wang fullname: Wang, Jigang email: jgwang@icmm.ac.cn organization: China Academy of Chinese Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40443720$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1uEzEQgFeoiJbSCw-AVuKCkFL8t2vvCUURpZFSBbVwtvwzaRx27WDvBnLjyq3PyJPgJqVqOXCxPZ5vPo3seV4c-OChKF5idIoRIu86E8gpRwQ1T4ojUgsxInVNDx6cD4uTlFYowxXGvEHPikOGGKOcoKPi19QvnXa9C778BDH8cBFsXv3vnzek1NtyotZJOeN8Oe6gdSGqHlJ5uYShU31wthzHfhmzIJUbp8rL-VWuvADrMpeT67DuQ8rJLDhzOgbdqtRnZOa-Qnm19WHjgtlm54vi6UK1CU7u9uPiy9mHz5Pz0Wz-cToZz0aG8boZcW2qRlcMaYWJFZoqrkhlRWOJwAhTyphZQGWsMoTiSrFG1wgLS4lYABhDj4vp3muDWsl1dJ2KWxmUk7uLEK-lir0zLcjKkooTYShtDDM11cAVtxVFOQZWq-x6v3etB92BNeD7qNpH0scZ75byOmwkJpgQLEQ2vLkzxPBtgNTLziUDbas8hCFJSjCjqOYcZfT1P-gqDNHnt8oUEY2g9U746mFL9738_fIMvN0DJoaUIizuEYzk7UjJ25GSu5HKMN7D310L2_-Q8mIyJ_uaPzuV0ZQ |
Cites_doi | 10.1002/med.21945 10.1038/s41598-022-21788-y 10.1038/s41584-023-00932-6 10.1093/bja/aet308 10.1038/sj.onc.1208530 10.1016/j.canlet.2013.10.002 10.1038/s41467-024-52142-7 10.1136/rmdopen-2019-001084 10.1016/j.addr.2024.115300 10.1016/j.biomaterials.2021.121063 10.1186/s13046-018-0868-2 10.1007/s40265-018-0982-7 10.1038/s41392-023-01331-9 10.2119/molmed.2015.00033 10.1161/HYPERTENSIONAHA.121.18778 10.1016/j.ijbiomac.2024.136620 10.1186/s13075-019-1935-6 10.1126/scitranslmed.abq4419 10.1002/adbi.202300538 10.1136/ard-2022-222708 10.1016/j.ijbiomac.2024.131440 10.1002/jcsm.13120 10.1016/j.biopha.2023.114900 10.7150/ijbs.91751 10.1038/nchembio.2211 10.1002/anie.201907853 10.1111/jgh.13664 10.1053/berh.2001.0195 10.1136/ard-2023-225237 10.1007/s00223-017-0373-1 10.1016/j.redox.2019.101319 10.1002/art.40787 10.1016/j.pharmthera.2022.108177 10.1016/j.cej.2024.155709 10.7150/ijbs.7730 10.1038/nrrheum.2017.49 10.1016/j.bcp.2012.11.016 10.7150/ijbs.69618 10.1186/s13075-017-1308-y 10.1016/j.chembiol.2022.06.011 10.1016/S1875-5364(23)60466-2 10.1038/nprot.2007.173 10.7150/thno.35219 10.1186/s12943-021-01390-y 10.3390/cells8040356 10.1186/s40779-022-00381-4 10.1002/ctm2.1148 10.1016/j.jare.2021.06.023 10.1016/j.cyto.2018.03.005 10.1016/j.biocel.2012.04.016 10.1002/eji.201041316 10.1016/j.clim.2022.108964 10.1161/ATVBAHA.110.210906 10.1016/j.ccr.2010.06.003 10.1038/s41467-021-27948-4 10.1016/j.apsb.2021.12.007 10.1136/ard-2023-224699 |
ContentType | Journal Article |
Copyright | 2025 The Author(s). published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. 2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. 2025. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2025 The Author(s). published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. – notice: 2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. – notice: 2025. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION NPM K9. 7X8 5PM DOA |
DOI | 10.1002/mco2.70209 |
DatabaseName | Wiley Online Library Open Access CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) CrossRef MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2688-2663 |
EndPage | n/a |
ExternalDocumentID | oai_doaj_org_article_5d25728c339c4c63be7a7d53039ce46a PMC12122188 40443720 10_1002_mco2_70209 MCO270209 |
Genre | researchArticle Journal Article |
GrantInformation_xml | – fundername: National Science and Technology Major Project of China funderid: 20242D0523402 – fundername: Project of Administration of Traditional Chinese Medicine of Guangdong Province of China funderid: 20241205 – fundername: National Key Research and Development Program of China funderid: 2020YFA0908000 – fundername: Science and Technology Project of Guangzhou City funderid: 2024A04J4155 – fundername: Project of Administration of Traditional Chinese Medicine of Guangdong Province of China grantid: 20241205 – fundername: National Science and Technology Major Project of China grantid: 20242D0523402 – fundername: Science and Technology Project of Guangzhou City grantid: 2024A04J4155 |
GroupedDBID | 0R~ 1OC 24P 53G 7X7 8FI 8FJ AAHHS ABUWG ACCFJ ACCMX ADPDF AEEZP AEQDE AFKRA AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS BENPR CCPQU EBS FYUFA GROUPED_DOAJ HMCUK IAO IHR INH ITC M~E OK1 OVD RPM TEORI UKHRP AAMMB AAYXX AEFGJ AGXDD AIDQK AIDYY CITATION WIN NPM K9. 7X8 5PM |
ID | FETCH-LOGICAL-c4769-7bc59b540ba12d8b3a7a25d89d281013344cfe5cdac2315a49b6018d328feecc3 |
IEDL.DBID | DOA |
ISSN | 2688-2663 |
IngestDate | Wed Aug 27 01:25:17 EDT 2025 Thu Aug 21 18:36:59 EDT 2025 Fri Jul 11 17:09:55 EDT 2025 Tue Aug 05 09:42:28 EDT 2025 Mon Jun 02 02:24:03 EDT 2025 Wed Aug 06 19:07:10 EDT 2025 Sat Jun 14 09:10:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | activity‐based protein profiling antioxidant peroxiredoxin‐2 rheumatoid arthritis capsaicin |
Language | English |
License | Attribution http://creativecommons.org/licenses/by/4.0 2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4769-7bc59b540ba12d8b3a7a25d89d281013344cfe5cdac2315a49b6018d328feecc3 |
Notes | Funding Hengkai He, Mingjing Hao, and Piao Luo contributed equally to this work. This work was supported by the National Science and Technology Major Project of China (2024ZD0523402), National Key Research and Development Program of China (2020YFA0908000), Science and Technology Project of Guangzhou City (2024A04J4155), and Project of Administration of Traditional Chinese Medicine of Guangdong Province of China (20241205). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Funding: This work was supported by the National Science and Technology Major Project of China (2024ZD0523402), National Key Research and Development Program of China (2020YFA0908000), Science and Technology Project of Guangzhou City (2024A04J4155), and Project of Administration of Traditional Chinese Medicine of Guangdong Province of China (20241205). |
ORCID | 0000-0002-0575-0105 |
OpenAccessLink | https://doaj.org/article/5d25728c339c4c63be7a7d53039ce46a |
PMID | 40443720 |
PQID | 3228983688 |
PQPubID | 5014760 |
PageCount | 15 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5d25728c339c4c63be7a7d53039ce46a pubmedcentral_primary_oai_pubmedcentral_nih_gov_12122188 proquest_miscellaneous_3214306770 proquest_journals_3228983688 pubmed_primary_40443720 crossref_primary_10_1002_mco2_70209 wiley_primary_10_1002_mco2_70209_MCO270209 |
PublicationCentury | 2000 |
PublicationDate | June 2025 |
PublicationDateYYYYMMDD | 2025-06-01 |
PublicationDate_xml | – month: 06 year: 2025 text: June 2025 |
PublicationDecade | 2020 |
PublicationPlace | China |
PublicationPlace_xml | – name: China – name: Beijing – name: Hoboken |
PublicationTitle | MedComm (2020) |
PublicationTitleAlternate | MedComm (2020) |
PublicationYear | 2025 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
References | 2021; 20 2010; 18 2023; 8 2019; 58 2024; 266 2005; 24 2022; 29 2023; 21 2020; 6 2021; 34 2022; 82 2019; 21 2017; 32 2022; 79 2024; 20 2001; 15 2021; 276 2007; 2 2018; 78 2011; 28 2018; 37 2014; 10 2021; 81 2019; 8 2019; 9 2019; 71 2023; 164 2018; 106 2023; 15 2024; 208 2023; 19 2013; 85 2011; 31 2024; 15 2022; 238 2022; 237 2016; 13 2014; 112 2024; 281 2023; 43 2017; 13 2022; 9 2015; 21 2024; 83 2022; 12 2020; 28 2022; 13 2011; 41 2022; 14 2017; 19 2024; 499 2017; 102 2012; 44 2016; 8 2022; 18 2014; 343 e_1_2_11_32_1 e_1_2_11_55_1 e_1_2_11_30_1 e_1_2_11_57_1 e_1_2_11_36_1 e_1_2_11_13_1 e_1_2_11_34_1 e_1_2_11_53_1 e_1_2_11_11_1 e_1_2_11_29_1 e_1_2_11_6_1 Chen X. (e_1_2_11_60_1) 2021; 81 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_48_1 e_1_2_11_2_1 e_1_2_11_20_1 e_1_2_11_47_1 e_1_2_11_24_1 e_1_2_11_41_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_43_1 e_1_2_11_17_1 e_1_2_11_15_1 e_1_2_11_59_1 e_1_2_11_38_1 e_1_2_11_19_1 e_1_2_11_50_1 e_1_2_11_10_1 e_1_2_11_31_1 e_1_2_11_56_1 e_1_2_11_58_1 e_1_2_11_14_1 e_1_2_11_35_1 e_1_2_11_52_1 e_1_2_11_12_1 e_1_2_11_33_1 e_1_2_11_54_1 e_1_2_11_7_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_49_1 Cho J.‐W. (e_1_2_11_45_1) 2011; 28 e_1_2_11_61_1 e_1_2_11_21_1 e_1_2_11_44_1 e_1_2_11_46_1 e_1_2_11_25_1 e_1_2_11_40_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_42_1 e_1_2_11_18_1 e_1_2_11_16_1 e_1_2_11_37_1 e_1_2_11_39_1 Zou L. (e_1_2_11_51_1) 2016; 8 |
References_xml | – volume: 8 issue: 2 year: 2023 article-title: Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria‐Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1 publication-title: Advanced Biology – volume: 15 start-page: 7791 issue: 1 year: 2024 article-title: Astrocyte‐derived Clusterin Disrupts Glial Physiology to Obstruct Remyelination in Mouse Models of Demyelinating Diseases publication-title: Nature Communications – volume: 85 start-page: 705 issue: 6 year: 2013 end-page: 717 article-title: The Nrf2 Cell Defence Pathway: Keap1‐dependent and ‐independent Mechanisms of Regulation publication-title: Biochemical Pharmacology – volume: 102 start-page: 533 issue: 5 year: 2017 end-page: 546 article-title: Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications publication-title: Calcified Tissue International – volume: 9 start-page: 4461 issue: 15 year: 2019 end-page: 4473 article-title: Vitamin C Kills Thyroid Cancer Cells Through ROS‐dependent Inhibition of MAPK/ERK and PI3K/AKT Pathways via Distinct Mechanisms publication-title: Theranostics – volume: 8 start-page: 68 issue: 1 year: 2023 article-title: Signaling Pathways in Rheumatoid Arthritis: Implications for Targeted Therapy publication-title: Signal Transduction and Targeted Therapy – volume: 20 start-page: 4601 issue: 12 year: 2024 end-page: 4617 article-title: Dissection of Targeting Molecular Mechanisms of Celastrol‐induced Nephrotoxicity viaa Combined Deconvolution Strategy of Chemoproteomics and Metabolomics publication-title: International Journal of Biological Sciences – volume: 106 start-page: 54 year: 2018 end-page: 66 article-title: Berberine Inhibits IL‐21/IL‐21R Mediated Inflammatory Proliferation of Fibroblast‐Like Synoviocytes Through the Attenuation of PI3K/Akt Signaling Pathway and Ameliorates IL‐21 Mediated Osteoclastogenesis publication-title: Cytokine – volume: 499 year: 2024 article-title: Mechanism of Self‐Assembled Celastrol‐Erianin Nanomedicine for Treatment of Breast Cancer publication-title: Chemical Engineering Journal – volume: 2 start-page: 1269 issue: 5 year: 2007 end-page: 1275 article-title: Collagen‐induced Arthritis publication-title: Nature Protocols – volume: 34 start-page: 43 year: 2021 end-page: 63 article-title: Activation of Nrf2/HO‐1 Signaling: An Important Molecular Mechanism of Herbal Medicine in the Treatment of Atherosclerosis via the Protection of Vascular Endothelial Cells From Oxidative Stress publication-title: Journal of Advanced Research – volume: 41 start-page: 2040 issue: 7 year: 2011 end-page: 2051 article-title: Nrf2 is Essential for Cholesterol Crystal‐induced Inflammasome Activation and Exacerbation of Atherosclerosis Nrf2 is Essential for Cholesterol Crystal‐induced Inflammasome Activation and Exacerbation of Atherosclerosis publication-title: European Journal of Immunology – volume: 112 start-page: 337 issue: 2 year: 2014 end-page: 347 article-title: Capsaicin 8% Patch for Treprostinil Subcutaneous Infusion Site Pain in Pulmonary Hypertension Patients publication-title: British Journal of Anaesthesia – volume: 276 year: 2021 article-title: Mutual‐reinforcing Sonodynamic Therapy Against Rheumatoid Arthritis Based on Sparfloxacin Sonosensitizer Doped Concave‐cubic Rhodium Nanozyme publication-title: Biomaterials – volume: 15 issue: 681 year: 2023 article-title: Additive Efficacy of a Bispecific Anti–TNF/IL‐6 Nanobody Compound in Translational Models of Rheumatoid Arthritis publication-title: Science Translational Medicine – volume: 28 start-page: 785 issue: 5 year: 2011 end-page: 792 article-title: Proteomic Analysis of Psoriatic Skin Tissue for Identification of Differentially Expressed Proteins: Up‐regulation of GSTP1, SFN and PRDX2 in Psoriatic Skin publication-title: International Journal of Molecular Medicine – volume: 15 start-page: 805 issue: 5 year: 2001 end-page: 829 article-title: Metalloproteases and Inhibitors in Arthritic Diseases publication-title: Best Practice & Research Clinical Rheumatology – volume: 343 start-page: 190 issue: 2 year: 2014 end-page: 199 article-title: Peroxiredoxin 2 Knockdown by RNA Interference Inhibits the Growth of Colorectal Cancer Cells by Downregulating Wnt/β‐catenin Signaling publication-title: Cancer Letters – volume: 164 year: 2023 article-title: Therapeutic Strategies for Rheumatic Diseases and Disorders: Targeting Redox Imbalance and Oxidative Stress publication-title: Biomedicine & Pharmacotherapy – volume: 14 start-page: 182 issue: 1 year: 2022 end-page: 197 article-title: Capsaicin Alleviates Cisplatin‐induced Muscle Loss and Atrophy in Vitro and in Vivo publication-title: Journal of Cachexia, Sarcopenia and Muscle – volume: 8 start-page: 3141 issue: 7 year: 2016 end-page: 3147 article-title: Relationship Between PI3K Pathway and Angiogenesis in CIA Rat Synovium publication-title: American journal of translational research – volume: 28 year: 2020 article-title: PRDX2 protects Against Oxidative Stress Induced by H. pylori and Promotes Resistance to Cisplatin in Gastric Cancer publication-title: Redox Biology – volume: 19 start-page: 111 issue: 1 year: 2017 article-title: Increased Serum Concentrations of IL‐1 Beta, IL‐21 and Th17 Cells in Overweight Patients With Rheumatoid Arthritis publication-title: Arthritis Research & Therapy – volume: 24 start-page: 3797 issue: 23 year: 2005 end-page: 3809 article-title: 2‐Methoxyestradiol‐induced Apoptosis in human Leukemia Cells Proceeds Through a Reactive Oxygen Species and Akt‐dependent Process publication-title: Oncogene – volume: 13 start-page: 38 issue: 1 year: 2016 end-page: 45 article-title: Profiling Drugs for Rheumatoid Arthritis That Inhibit Synovial Fibroblast Activation publication-title: Nature Chemical Biology – volume: 6 issue: 1 year: 2020 article-title: Management of Fatigue in Rheumatoid Arthritis publication-title: RMD Open – volume: 19 start-page: 288 issue: 5 year: 2023 end-page: 306 article-title: Genetics and Epigenetics of Primary Sjögren Syndrome: Implications for Future Therapies publication-title: Nat Rev Rheumatol – volume: 81 start-page: 85 issue: 1 year: 2021 end-page: 97 article-title: METTL3‐mediated M A Modification of ATG7 Regulates Autophagy‐GATA4 Axis to Promote Cellular Senescence and Osteoarthritis Progression publication-title: Annals of the Rheumatic Diseases – volume: 79 start-page: 906 issue: 5 year: 2022 end-page: 917 article-title: Capsaicin Attenuates Arterial Calcification through Promoting SIRT6‐Mediated Deacetylation and Degradation of Hif1α (Hypoxic‐Inducible Factor‐1 Alpha) publication-title: Hypertension – volume: 21 start-page: 730 issue: 10 year: 2023 end-page: 744 article-title: Tripterygium Hypoglaucum Extract Ameliorates Adjuvant‐induced Arthritis in Mice Through the Gut Microbiota publication-title: Chinese Journal of Natural Medicines – volume: 8 start-page: 356 issue: 4 year: 2019 article-title: Activation of Nrf2/HO‐1 Pathway and Human Atherosclerotic Plaque Vulnerability:An in Vitro and in Vivo Study publication-title: Cells – volume: 238 year: 2022 article-title: Anti‐cancer Activity of Sustained Release Capsaicin Formulations publication-title: Pharmacology & Therapeutics – volume: 13 start-page: 676 issue: 1 year: 2022 article-title: TNF Antagonist Sensitizes Synovial Fibroblasts to Ferroptotic Cell Death in Collagen‐induced Arthritis Mouse Models publication-title: Nature Communications – volume: 12 issue: 12 year: 2022 article-title: Artemisitene Suppresses Rheumatoid Arthritis Progression via Modulating METTL3‐mediated N6‐methyladenosine Modification of ICAM2 mRNA in Fibroblast‐Like Synoviocytes publication-title: Clinical and translational medicine – volume: 71 start-page: 703 issue: 5 year: 2019 end-page: 711 article-title: Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis publication-title: Arthritis & Rheumatology – volume: 10 start-page: 285 issue: 3 year: 2014 end-page: 295 article-title: Capsaicin Mediates Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells via Stabilizing and Activating p53 publication-title: International Journal of Biological Sciences – volume: 20 start-page: 101 issue: 1 year: 2021 article-title: CircDIDO1 inhibits Gastric Cancer Progression by Encoding a Novel DIDO1‐529aa Protein and Regulating PRDX2 Protein Stability publication-title: Molecular Cancer – volume: 12 start-page: 2300 issue: 5 year: 2022 end-page: 2314 article-title: Celastrol Induces Ferroptosis in Activated HSCs to Ameliorate Hepatic Fibrosis via Targeting Peroxiredoxins and HO‐1 publication-title: Acta Pharmaceutica Sinica B – volume: 281 year: 2024 article-title: Transcriptome Profiling of Canine Parvovirus 2 Nonstructural Gene 1(CPV2.NS1) Transfected 4T1 Mice Mammary Tumor Cells to Elucidate Its Oncolytic Effects publication-title: International Journal of Biological Macromolecules – volume: 18 start-page: 88 issue: 1 year: 2010 end-page: 98 article-title: PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3 publication-title: Cancer Cell – volume: 32 start-page: 1212 issue: 6 year: 2017 end-page: 1220 article-title: Peroxiredoxin‐2 Up‐regulation in Inflammatory Bowel Disease: Friend or Foe? publication-title: Journal of Gastroenterology and Hepatology – volume: 43 start-page: 1038 issue: 4 year: 2023 end-page: 1067 article-title: Transient Receptor Potential Vanilloid 1 (TRPV1)‐independent Actions of Capsaicin on Cellular Excitability and Ion Transport publication-title: Medicinal Research Reviews – volume: 44 start-page: 1223 issue: 8 year: 2012 end-page: 1231 article-title: Lymphocytes From Rheumatoid Arthritis Patients Have Elevated Levels of Intracellular Peroxiredoxin 2, and a Greater Frequency of Cells With Exofacial Peroxiredoxin 2, Compared With Healthy human Lymphocytes publication-title: The International Journal of Biochemistry & Cell Biology – volume: 83 start-page: 599 issue: 5 year: 2024 end-page: 607 article-title: Comparison of the Effect of Treatment With NSAIDs Added to Anti‐TNF Therapy versus Anti‐TNF Therapy Alone on the Progression of Structural Damage in the Spine Over 2 Years in Patients With Radiographic Axial Spondyloarthritis From the Randomised‐controlled CONSUL Trial publication-title: Annals of the Rheumatic Diseases – volume: 13 start-page: 291 issue: 5 year: 2017 end-page: 301 article-title: Immunometabolism in Early and Late Stages of Rheumatoid Arthritis publication-title: Nature Reviews Rheumatology – volume: 266 year: 2024 article-title: Polysaccharides From Polygonatum Kingianum Collett & Hemsl Ameliorated Fatigue by Regulating NRF2/HO‐1/NQO1 and AMPK/PGC‐1α/TFAM Signaling Pathways, and Gut Microbiota publication-title: International Journal of Biological Macromolecules – volume: 58 start-page: 14715 issue: 41 year: 2019 end-page: 14723 article-title: Design, Synthesis, and Phenotypic Profiling of Pyrano‐Furo‐Pyridone Pseudo Natural Products publication-title: Angewandte Chemie International Edition – volume: 208 year: 2024 article-title: Therapeutic Delivery Systems for Rheumatoid Arthritis Based on Hydrogel Carriers publication-title: Advanced Drug Delivery Reviews – volume: 82 start-page: 198 issue: 2 year: 2022 end-page: 211 article-title: PU.1 Promotes Development of Rheumatoid Arthritis via Repressing FLT3 in Macrophages and Fibroblast‐Like Synoviocytes publication-title: Annals of the Rheumatic Diseases – volume: 9 start-page: 22 issue: 1 year: 2022 article-title: Celastrol Mitigates Inflammation in Sepsis by Inhibiting the PKM2‐dependent Warburg Effect publication-title: Military Medical Research – volume: 83 start-page: 550 issue: 5 year: 2024 end-page: 555 article-title: Shift in Perspective: Autoimmunity Protecting Against Rheumatoid Arthritis publication-title: Annals of the Rheumatic Diseases – volume: 12 issue: 1 year: 2022 article-title: Differential Effects of Periodontal Microbiome on the Rheumatoid Factor Induction During Rheumatoid Arthritis Pathogenesis publication-title: Scientific Reports – volume: 18 start-page: 2003 issue: 5 year: 2022 end-page: 2017 article-title: Dissection of Targeting Molecular Mechanisms of Aristolochic Acid‐induced Nephrotoxicity a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics publication-title: International Journal of Biological Sciences – volume: 37 start-page: 197 issue: 1 year: 2018 article-title: Inhibitory Effects of Low Intensity Pulsed Ultrasound on Osteoclastogenesis Induced in Vitro by Breast Cancer Cells publication-title: Journal of Experimental & Clinical Cancer Research – volume: 237 year: 2022 article-title: Peroxiredoxin 4 Regulates Tumor‐cell‐Like Characteristics of Fibroblast‐Like Synoviocytes in Rheumatoid Arthritis Through PI3k/Akt Signaling Pathway publication-title: Clinical Immunology – volume: 29 start-page: 1248 issue: 8 year: 2022 end-page: 1259 article-title: Capsaicin Ameliorates Inflammation in a TRPV1‐independent Mechanism by Inhibiting PKM2‐LDHA‐mediated Warburg Effect in Sepsis publication-title: Cell Chemical Biology – volume: 21 start-page: 153 issue: 1 year: 2019 article-title: A Novel Function of artesunate on Inhibiting Migration and Invasion of Fibroblast‐Like Synoviocytes From Rheumatoid Arthritis Patients publication-title: Arthritis Research & Therapy – volume: 21 start-page: 98 issue: 1 year: 2015 end-page: 108 article-title: Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release Through a Novel Mechanism of Redox‐Dependent Secretion publication-title: Molecular Medicine – volume: 31 start-page: 58 issue: 1 year: 2011 end-page: 66 article-title: NF‐E2–Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology – volume: 78 start-page: 1489 issue: 14 year: 2018 end-page: 1500 article-title: Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain publication-title: Drugs – ident: e_1_2_11_13_1 doi: 10.1002/med.21945 – ident: e_1_2_11_7_1 doi: 10.1038/s41598-022-21788-y – ident: e_1_2_11_4_1 doi: 10.1038/s41584-023-00932-6 – ident: e_1_2_11_39_1 doi: 10.1093/bja/aet308 – ident: e_1_2_11_17_1 doi: 10.1038/sj.onc.1208530 – ident: e_1_2_11_44_1 doi: 10.1016/j.canlet.2013.10.002 – ident: e_1_2_11_50_1 doi: 10.1038/s41467-024-52142-7 – ident: e_1_2_11_30_1 doi: 10.1136/rmdopen-2019-001084 – ident: e_1_2_11_35_1 doi: 10.1016/j.addr.2024.115300 – ident: e_1_2_11_15_1 doi: 10.1016/j.biomaterials.2021.121063 – ident: e_1_2_11_59_1 doi: 10.1186/s13046-018-0868-2 – ident: e_1_2_11_38_1 doi: 10.1007/s40265-018-0982-7 – ident: e_1_2_11_2_1 doi: 10.1038/s41392-023-01331-9 – ident: e_1_2_11_31_1 doi: 10.2119/molmed.2015.00033 – ident: e_1_2_11_10_1 doi: 10.1161/HYPERTENSIONAHA.121.18778 – ident: e_1_2_11_49_1 doi: 10.1016/j.ijbiomac.2024.136620 – volume: 8 start-page: 3141 issue: 7 year: 2016 ident: e_1_2_11_51_1 article-title: Relationship Between PI3K Pathway and Angiogenesis in CIA Rat Synovium publication-title: American journal of translational research – ident: e_1_2_11_33_1 doi: 10.1186/s13075-019-1935-6 – ident: e_1_2_11_36_1 doi: 10.1126/scitranslmed.abq4419 – ident: e_1_2_11_23_1 doi: 10.1002/adbi.202300538 – ident: e_1_2_11_24_1 doi: 10.1136/ard-2022-222708 – volume: 28 start-page: 785 issue: 5 year: 2011 ident: e_1_2_11_45_1 article-title: Proteomic Analysis of Psoriatic Skin Tissue for Identification of Differentially Expressed Proteins: Up‐regulation of GSTP1, SFN and PRDX2 in Psoriatic Skin publication-title: International Journal of Molecular Medicine – ident: e_1_2_11_54_1 doi: 10.1016/j.ijbiomac.2024.131440 – ident: e_1_2_11_11_1 doi: 10.1002/jcsm.13120 – ident: e_1_2_11_20_1 doi: 10.1016/j.biopha.2023.114900 – ident: e_1_2_11_21_1 doi: 10.7150/ijbs.91751 – ident: e_1_2_11_27_1 doi: 10.1038/nchembio.2211 – ident: e_1_2_11_9_1 doi: 10.1002/anie.201907853 – ident: e_1_2_11_46_1 doi: 10.1111/jgh.13664 – ident: e_1_2_11_29_1 doi: 10.1053/berh.2001.0195 – ident: e_1_2_11_3_1 doi: 10.1136/ard-2023-225237 – ident: e_1_2_11_37_1 doi: 10.1007/s00223-017-0373-1 – ident: e_1_2_11_43_1 doi: 10.1016/j.redox.2019.101319 – ident: e_1_2_11_28_1 doi: 10.1002/art.40787 – ident: e_1_2_11_12_1 doi: 10.1016/j.pharmthera.2022.108177 – ident: e_1_2_11_22_1 doi: 10.1016/j.cej.2024.155709 – ident: e_1_2_11_40_1 doi: 10.7150/ijbs.7730 – ident: e_1_2_11_25_1 doi: 10.1038/nrrheum.2017.49 – ident: e_1_2_11_56_1 doi: 10.1016/j.bcp.2012.11.016 – ident: e_1_2_11_42_1 doi: 10.7150/ijbs.69618 – ident: e_1_2_11_47_1 doi: 10.1186/s13075-017-1308-y – ident: e_1_2_11_26_1 doi: 10.1016/j.chembiol.2022.06.011 – ident: e_1_2_11_8_1 doi: 10.1016/S1875-5364(23)60466-2 – ident: e_1_2_11_32_1 doi: 10.1038/nprot.2007.173 – ident: e_1_2_11_14_1 doi: 10.7150/thno.35219 – ident: e_1_2_11_18_1 doi: 10.1186/s12943-021-01390-y – ident: e_1_2_11_58_1 doi: 10.3390/cells8040356 – ident: e_1_2_11_41_1 doi: 10.1186/s40779-022-00381-4 – ident: e_1_2_11_52_1 doi: 10.1002/ctm2.1148 – ident: e_1_2_11_53_1 doi: 10.1016/j.jare.2021.06.023 – ident: e_1_2_11_48_1 doi: 10.1016/j.cyto.2018.03.005 – ident: e_1_2_11_19_1 doi: 10.1016/j.biocel.2012.04.016 – ident: e_1_2_11_57_1 doi: 10.1002/eji.201041316 – ident: e_1_2_11_5_1 doi: 10.1016/j.clim.2022.108964 – ident: e_1_2_11_55_1 doi: 10.1161/ATVBAHA.110.210906 – volume: 81 start-page: 85 issue: 1 year: 2021 ident: e_1_2_11_60_1 article-title: METTL3‐mediated M 6A Modification of ATG7 Regulates Autophagy‐GATA4 Axis to Promote Cellular Senescence and Osteoarthritis Progression publication-title: Annals of the Rheumatic Diseases – ident: e_1_2_11_16_1 doi: 10.1016/j.ccr.2010.06.003 – ident: e_1_2_11_6_1 doi: 10.1038/s41467-021-27948-4 – ident: e_1_2_11_61_1 doi: 10.1016/j.apsb.2021.12.007 – ident: e_1_2_11_34_1 doi: 10.1136/ard-2023-224699 |
SSID | ssj0002511790 |
Score | 2.2934387 |
Snippet | ABSTRACT
Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own... Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own tissues,... ABSTRACT Rheumatoid arthritis (RA), a prevalent and incurable autoimmune disease globally, is characterized by the immune system attacking the body's own... |
SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e70209 |
SubjectTerms | activity‐based protein profiling antioxidant capsaicin Original peroxiredoxin‐2 rheumatoid arthritis |
SummonAdditionalLinks | – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKkRAXxJu0BRnBCSk0sZ3ElriUFauCWFq1VOot8itshBqvNrtV98aVG7-RX8LYyaasQEjcoszEcTwz9pex_Rmhl5VQVa6NjlNtVcxsUsRSMx3z1NpEpTqrTFgg-yk_PGMfzrPzLfRmvRem44cYEm4-MkJ_7QNcqnb_mjT0QjvyugC0I26gm35vrV_QR9jxkGHx4LkISRaSe3eAsXXgJyX7149vjEiBuP9vaPPPRZO_g9kwGo3vojs9jMQHnd3voS3b3Ee3Jv1E-QP0_X0zrVVYjoWP7dxd1Z4Y9Kpufn77QbBa4ZGctdIr44MLaAjvCLbFJ1O7BAjrauOLngbCI3xZS3xydApPTsK5HhaEMzdbuBaEUMAYmtEpQOELUPlYf7X4dNW4y9rpFZT5EJ2N330eHcb9qQuxZkUu4kLpTCgAckqmxHBFZSFJZrgwxJOBUcqYrmymjdSADTPJhIKfOm4o4ZUFh6CP0HbjGvsEYZ5WlFtecAmgpahAKZMioVoKJgmrSIRerFu-nHXkGmVHo0xKb58y2CdCb71RBg1PiB1uuPmXso-vMjPQ9xCuKRXgajlVtpCFyWCAFtqyXEZob23Sso_StoTOjAtOwTsi9HwQQ3z5SRPZWLf0OoAoPc1eEqHHnQcMNWEJ89OeIOEbvrFR1U1JU08Dh3cKkAHQFbz4VXCjf3x_ORkdkXC18z_Ku-g28WcVh4zRHtpezJf2KQCohXoW4uQXXaQbGQ priority: 102 providerName: Wiley-Blackwell |
Title | Inhibition Peroxiredoxin‐2 by Capsaicin Ameliorates Rheumatoid Arthritis via ROS‐Mediated Apoptosis in Fibroblast‐Like Synoviocytes |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmco2.70209 https://www.ncbi.nlm.nih.gov/pubmed/40443720 https://www.proquest.com/docview/3228983688 https://www.proquest.com/docview/3214306770 https://pubmed.ncbi.nlm.nih.gov/PMC12122188 https://doaj.org/article/5d25728c339c4c63be7a7d53039ce46a |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLZgSIgL4jfZRmUEJ6SwxHZi-7hVqwaiW9UxqbfIdhw1gsXV2k7rjSs3_kb-Ep6drGoFgguXKMp7cRy_Z_tz_PI9hN5WUle5KU2cGqtjZhMeK8NMLFJrE52arCpDgOxpfnLBPk6yyUaqLx8T1tIDtw13kJXgVEQYSiWUkVNtueJlBiOvNJblARrBnLexmPJjsAfOXCZrPlJycGkcec8BHMmtGSgQ9f8JXf4eJLkJXsPsM3iEHnawER-21X2M7tjmCbo_7DbGn6LvH5pprUP4FR7ZK3dTeyLQm7r5-e0HwXqF-2o2V14ZH17ar_6_fMCYeDy1S4Csri590dNAcISva4XHZ-dw5zDk8bAgnLnZws1BCAUMYIXtNKDuBah8qr9YfL5q3HXtzArKfIYuBsef-ydxl2UhNoznMubaZFIDcNMqJaXQVHFFslLIknjyL0oZM5XNTKkMYMFMMalhESdKSkRlwQHoc7TTuMa-RFikFRVWcKEApPAKlDIlE2qUZIqwikTozW3LF7OWTKNoaZNJ4e1TBPtE6MgbZa3hCbDDBXCLonOL4l9uEaH9W5MWXa-cFzB4CSloLkSEXq_F0J_8JolqrFt6HUCQnlYvidCL1gPWNWEJ89ucIBFbvrFV1W1JU08DZ3cKEAHQFDz4XXCjv7x_MeyfkXC2-z9aYg89ID5ncfhytI92FldL-wqA1EL30F3CRnDkE95D946OT0fjXuhHvfDV6xfVhyU6 |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSNAL4lkCBYLghBSa2E5sH8uK1RZ226oPqbfIr7BR1Xi1j6p748qN38gvYexNU1YgJG5RZuw4nhn7y9j5jNC7Sqiq0EYnmbYqoTZlidRUJzyzNlWZzisTNsjuF4NT-vksP2v35vh_YVb8EF3CzUdGGK99gPuE9M4Na-iFdvgDA7gjbqM7tMDMH2CA6WGXYvHomYUsCy68P8Dk2hGU4p2b4mtTUmDu_xvc_HPX5O9oNkxH_Qfofosj492V4R-iW7Z5hO6O2pXyx-j7XjOuVdiPFR_aqbuqPTPoVd38_PYDx2oZ9-RkJr1yvHsBPeE9wc7io7FdAIZ1tfFVjwPjUXxZy_jo4BhKjsLBHhaEEzeZuxkIoYI-9KNTAMPnoDKsz218vGzcZe30Eup8gk77n056g6Q9diHRlBUiYUrnQgGSUzLDhisimcS54cJgzwZGCKW6srk2UgM4zCUVCr7quCGYVxY8gjxFG41r7DMU86wi3HLGJaAWVoFSLkVKtBRUYlrhCL297vlysmLXKFc8yrj09imDfSL00Rul0_CM2OGGm34t2wArcwODD-aaEAG-VhBlmWQmhxlaaEsLGaHta5OWbZjOShjNuOAEvCNCbzoxBJhfNZGNdQuvA5DS8-ylEdpaeUDXEppSv-4JEr7mG2tNXZc09TiQeGeAGQBewYPfBzf6x_uXo94BDlfP_0f5Nbo3OBkNy-He_pcXaBP7g4tD-mgbbcynC_sS0NRcvQox8wuVHB6F |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKkSouiHcDBYLghBSa2E5iS1zKwqqFbrtqqdRb5FfYCDWO9lF1b1y58Rv5JYydbMoKhMQtyowdxzNjfxk7nxF6VXJZZkqrKFFGRtTEeSQUVRFLjIllotJS-w2yR9n-Gf14np5voLerf2Fafog-4eYiw4_XLsAbXe5ek4ZeKIvf5IB2-A100632uQ1dmI77DIsDz7lPsuDMuQPMrT0_Kd69Lr42I3ni_r-hzT83Tf4OZv1sNLyDbncwMtxr7X4XbZj6HtoadQvl99H3g3pSSb8dKxybqb2qHDHoVVX__PYDh3IZDkQzE0453LuAjnCOYGbhycQsAMLaSruqJ57wKLysRHhyfAolR_5cDwPCxjZzOwMhVDCEbrQSUPgcVA6rryY8Xdb2srJqCXU-QGfDD58H-1F36kKkaJ7xKJcq5RKAnBQJ1kwSkQucasY1dmRghFCqSpMqLRRgw1RQLuGjjmmCWWnAIchDtFnb2myjkCUlYYblTABoyUtQSgWPiRKcCkxLHKCXq54vmpZco2hplHHh7FN4-wTonTNKr-EIsf0NO_1SdPFVpBrGHswUIRxcLSPS5CLXKUzQXBmaiQDtrExadFE6K2AwY5wR8I4AvejFEF9u0UTUxi6cDiBKR7MXB-hR6wF9S2hM3bInSNiab6w1dV1SVxPP4Z0AZAB0BQ9-7d3oH-9fjAbH2F89_h_l52hr_H5YHB4cfXqCbmF3bLFPHu2gzfl0YZ4ClprLZz5kfgHWJx23 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+Peroxiredoxin-2+by+Capsaicin+Ameliorates+Rheumatoid+Arthritis+via+ROS-Mediated+Apoptosis+in+Fibroblast-Like+Synoviocytes&rft.jtitle=MedComm+%282020%29&rft.au=He%2C+Hengkai&rft.au=Hao%2C+Mingjing&rft.au=Luo%2C+Piao&rft.au=Chen%2C+Junhui&rft.date=2025-06-01&rft.eissn=2688-2663&rft.volume=6&rft.issue=6&rft.spage=e70209&rft_id=info:doi/10.1002%2Fmco2.70209&rft_id=info%3Apmid%2F40443720&rft.externalDocID=40443720 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2688-2663&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2688-2663&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2688-2663&client=summon |